CAMBRIDGE, Massachusetts and TORONTO, Ontario, Aug. 01, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (PMN), a biotechnology company focused on the generation and development of therapeutics ...
JUPITER, FL / ACCESS Newswire / January 27, 2026 / Jupiter Neurosciences, Inc. (NASDAQ:JUNS), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based platform for ...
Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based platform, is pleased to announce that ...
Welcome to the registration form for the 12th Annual NEURAL Conference, which will take place in person on June 24-26, 2026, at the University of Alabama at Birmingham (UAB). THIS FORM IS FOR NON-UAB ...
(RTTNews) - Jupiter Neurosciences, Inc. (JUNS), a clinical-stage pharmaceutical company, is scheduled to participate in the DealFlow Discovery Conference, taking place January 28-29, 2026. The company ...
Welcome to the registration form for the 12th Annual NEURAL Conference, which will take place in person on June 24-26, 2026, at the University of Alabama at Birmingham (UAB). Any questions regarding ...
Fortis Institute of minimally invasive brain & spine surgery inaugurated at the first annual neurosciences conclave in Mumbai: Our Bureau, Mumbai Wednesday, March 25, 2026, 17:35 ...